المؤلفون: S. Gumenyuk A., A. Shchikota M., I. Pogonchenkova V., С. Гуменюк А., А. Щикота М., И. Погонченкова В.

المصدر: Russian Sklifosovsky Journal "Emergency Medical Care"; Том 10, № 1 (2021); 161-167 ; Журнал им. Н.В. Склифосовского «Неотложная медицинская помощь»; Том 10, № 1 (2021); 161-167 ; 2541-8017 ; 2223-9022 ; 10.23934/2223-9022-2021-10-1

مصطلحات موضوعية: acute myocardial infarction, acute ischemic stroke, endovascular care, aviation medical teams, острый инфаркт миокарда, острый ишемический инсульт, эндоваскулярная помощь, авиамедицинские бригады

وصف الملف: application/pdf

Relation: https://www.jnmp.ru/jour/article/view/1084/932; World Health Organization, cardiovascular diseases URL: https://www.who.int/cardiovascular_diseases/about_cvd/en/ [Дата обращения 16 февраля 2021г.].; Powers WJ, Rabinstein AA, Ackerson T, Adeoye OM, Bambakidis NC, Becker K, et al. 2018 guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American. Stroke Association. Stroke. 2018;49(3):e46–e110. PMID: 29367334 https://doi.org/10.1161/STR.0000000000000158; Шпектор А.В., Васильева Е.Ю., Шамалов Н.А., Скрыпник Д.В., Анисимов К.В. Организация системы эндоваскулярной помощи больным с ишемическими инсультами в городе Москве. В кн.: Хрипун А.И. (ред.) Сборник тезисов научных работ, представленных на присуждение премии в 2019 году. Москва; 2019. с. 31–32. URL: https://elibrary.ru/download/elibrary_39950263_78395059.pdf [Дата обращения 16 февраля 2021г.].; Глезер М.Г., Асташкин Е.И. Первичная ангиопластика и фармакоинвазивный подход в лечении инфаркта миокарда с подъемом сегмента ST на электрокардиограмме. Кардиоваскулярная терапия и профилактика. 2019;18(2):94–103.; Ibanez B, James S, Agewall S, Antunes MJ, Bucciarelli-Ducci C, Bueno H, et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with STsegment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2018;39(2):119–177. PMID: 28886621 https://doi.org/10.1093/eurheartj/ehx393; Васильева Е.Ю., Плавунов Н.Ф., Калинская А.И., Саввинова П.П., Сапина А.И., Введенский Г.А., и др. Организация «инфарктной сети» в Москве и результаты ее работы за пятилетний период. Эндоваскулярная хирургия. 2018;5(2):288–294.; Гуменюк С.А. Санитарно-авиационная эвакуация пациентов с острым коронарным синдромом и острым нарушением мозгового кровообращения. Медицина катастроф. 2020;(1):54–56.; Świeżewski SP, Wejnarski A, Leszczyński PK, Wojak A, Fronczak A, Darocha T, et al. Characteristics of urban versus rural utilization of the Polish Helicopter Emergency Medical Service in patients with ST-segment elevation myocardial infarction. Kardiol Pol. 2020;78(4):284–291. PMID: 32063599 https://doi.org/10.33963/KP.15190; Funder KS, Rasmussen LS, Siersma V, Lohse N, Hesselfeldt R, Pedersen F, et al. Helicopter vs. ground transportation of patients bound for primary percutaneous coronary intervention. Acta Anaesthesiol Scand. 2018;62(4):568–578. PMID: 29484640 https://doi.org/10.1111/aas.13092; Gunnarsson SI, Mitchell J, Busch MS, Larson B, Gharacholou SM, Li Z, et al. Outcomes of physician-staffed versus nonphysician-staffed helicopter transport for ST-elevation myocardial infarction. J Am Heart Assoc. 2017;6(2):e004936. PMID: 28154162 https://doi.org/10.1161/JAHA.116.004936; Trimmel H, Bayer T, Schreiber W, Voelckel WG, Fiedler L. Emergency management of patients with ST-segment elevation myocardial infarction in Eastern Austria: a descriptive quality control study. Scand J Trauma Resusc Emerg Med. 2018;26(1):38. PMID: 29739432 https://doi.org/10.1186/s13049-018-0504-3; Kimura Y, Ohba K, Sumida H, Tsujita K, Hirose T, Maruyama H, et al. A survival case of cardiogenic shock due to left main coronary artery myocardial infarction: successful cooperation with on-site percutaneous coronary intervention and helicopter emergency medical service. Intern Med. 2012;51(14):1845–1850. PMID: 22821098 https://doi.org/10.2169/internalmedicine.51.7442; Zakariassen E, Østerås Ø, Nystøyl DS, Breidablik HJ, Solheim E, Brattebø G, et al. Loss of life years due to unavailable helicopter emergency medical service: a single base study from a rural area of Norway. Scand J Prim Health Care. 2019;37(2):233–241. PMID: 31033360 https://doi.org/10.1080/02813432.2019.1608056; Alstrup K, Møller TP, Knudsen L, Hansen TM, Petersen JAK, Rognås L, et al. Characteristics of patients treated by the Danish Helicopter Emergency Medical Service from 2014–2018: a nationwide population-based study. Scand J Trauma Resusc Emerg Med. 2019;27(1):102. PMID: 31699120 https://doi.org/10.1186/s13049-019-0672-9; Moens D, Stipulante S, Donneau AF, Hartstein G, Pirotte O, D’orio V, et al. Air versus ground transport of patients with acute myocardial infarction: experience in a rural-based helicopter medical service. Eur J Emerg Med. 2015;22(4):273–278. PMID: 24736468 https://doi.org/10.1097/MEJ.0000000000000149; Fjaeldstad A, Kirk MH, Knudsen L, Bjerring J, Christensen EF. Physician-staffed emergency helicopter reduces transportation time from alarm call to highly specialized centre. Dan Med J. 2013;60(7):A4666. PMID: 23809975; Vesterbacka J, Eriksson A. A rural ambulance helicopter system in northern Sweden. Air Med J. 2001;20(3):28–31. PMID: 11331824; Trojanowski J, MacDonald RD. Safe transport of patients with acute coronary syndrome or cardiogenic shock by skilled air medical crews. Prehosp Emerg Care. 2011;15(2):240–245. PMID: 21226552 https://doi.org/10.3109/10903127.2010.541978; Świeżewski SP, Rzońca P, Panczyk M, Panczyk M, Leszczyński PK, Gujski M, et al. Polish Helicopter Emergency Medical Service (HEMS) Response to Stroke: A Five-Year Retrospective Study. Med Sci Monit. 2019;25:6547–6553. PMID: 31473759 https://doi.org/10.12659/MSM.915759; Hutton CF, Fleming J, Youngquist S, Hutton KC, Heiser DM, Barton ED. Stroke and Helicopter Emergency Medical Service Transports: An Analysis of 25,332 Patients. Air Med J. 2015;34(6):348–356. PMID: 26611222 https://doi.org/10.1016/j.amj.2015.06.011; Olson MD, Rabinstein AA. Does helicopter emergency medical service transfer offer benefit to patients with stroke? Stroke. 2012;43(3):878–880. PMID: 22156702 https://doi.org/10.1161/STROKEAHA.111.640987; Ono Y, Satou M, Ikegami Y, Shimadaet J, Hasegawa A, Tsukada Y, et al. Activation intervals for a helicopter emergency medical service in Japan. Air Med J. 2013;32(6):346–349. PMID: 24182885 https://doi.org/10.1016/j.amj.2013.01.006; Mommsen P, Bradt N, Zeckey C, Andruszkow H, Petri M, Frink M, et al. Comparison of helicopter and ground emergency medical service: a retrospective analysis of a German rescue helicopter base. Technol Health Care. 2012;20(1):49–56. PMID: 22297713 https://doi.org/10.3233/THC-2011-0655; Silbergleit R, Scott PA, Lowell MJ, Silberglei R. Cost-effectiveness of helicopter transport of stroke patients for thrombolysis. Acad Emerg Med. 2003;10(9):966–972. https://doi.org/10.1197/S1069-6563(03)00316-6; https://www.jnmp.ru/jour/article/view/1084

الاتاحة: https://www.jnmp.ru/jour/article/view/1084
https://doi.org/10.23934/2223-9022-2021-10-1-161-167

المؤلفون: N. Karpova Yu., M. Rashid A., N. Shostak A., I. Pogonchenkova V., T. Kazakova V., Н. Карпова Ю., М. Рашид А., Н. Шостак А., И. Погонченкова В., Т. Казакова В.

المصدر: Rational Pharmacotherapy in Cardiology; Vol 11, No 4 (2015); 431-437 ; Рациональная Фармакотерапия в Кардиологии; Vol 11, No 4 (2015); 431-437 ; 2225-3653 ; 1819-6446 ; 10.20996/1819-6446-2015-11-4

مصطلحات موضوعية: calcified aortic stenosis, ischemic heart disease, cytoprotectors, trimetazidine, heart bioenergy, кальцинированный аортальный стеноз, ишемическая болезнь сердца, цитопротекторы, триметазидин, биоэнергетика сердца

وصف الملف: application/pdf

Relation: https://www.rpcardio.com/jour/article/view/174/170; Global status report on noncommunicable diseases 2010. Geneva: WHO; 2011.; Shalnova SA, Deev AD, Karpov YA. Arterial hypertension and coronary heart disease in actual practice cardiologist. Kardiovaskulyarnaya Terapiya i Profilaktika 2006; (1): 73-80. In Russian (Шальнова С.А., Деев А.Д., Карпов Ю.А. Артериальная гипертония и ишемическая болезнь сердца в реальной практике врача-кардиолога. Кардиоваскулярная Терапия и Профилактика 2006;(1): 73-80).; Schukin YV, Ryabov AE. Chronic ischemic heart disease in the elderly and senile age. Manual for physicians. Samara: Volga-Business; 2008. In Russian (Щукин Ю.В., Рябов А.Е. Хроническая ишемическая болезнь сердца в пожилом и старческом возрасте. Пособие для врачей. Самара: Волга-Бизнес; 2008).; Kosarev VV, Babanov SA. Occupational diseases of medical workers. Samara: Ofort; 2009. In Russian (Косарев В.В., Бабанов С.А. Профессиональные заболевания медицинских работников. Самара: Офорт; 2009).; Karpova NY, MA Rashid, Kazakova TV, Shostak NA Aortic stenosis. Russkiy Meditsinskiy Zhurnal 2014; 22 (2): 162-5. In Russian (Карпова Н.Ю., Рашид М.А., Казакова Т.В., Шостак Н.А. Аортальный стеноз. Русский Медицинский Журнал 2014; 22(2): 162-5).; Lindman B.R., Bonow R.O., Otto C.M. Current management of calcific aortic stenosis. CircRes 2013;113(2):223-37.; Ortlepp J.R., Schmitz F., Bozoglu T. et al. Cardiovascular risk factors in patients with aortic stenosis predict prevalence of coronary artery disease but not of aortic stenosis: an angiographic pair matched casecontrol study. Heart 2003;89:1019-22.; Otto C., O'Brien K.D. Why is there discordance between calcific aortic stenosis and coronary artery disease? Heart 2001;85:601-2.; Freeman R.V., Otto C.M. Spectrum of calcific aortic valve disease: pathogenesis, disease progression, and treatment strategies. Circulation 2005;111:3316-26.; Karpova NY, Shostak NA, Rashid MA et al. Calcined aortic stenosis. Moscow: Media Sphere; 2011. In Russian (Карпова Н.Ю., Шостак Н.А., Рашид М.А. и др. Кальцинированный аортальный стеноз. Москва: Медиа Сфера; 2011).; Demer L.L. Boning up (or down) on statins. Arterioscler Thromb Vasc Biol 2001;21:1565-6.; Otto C.M., Kuusisto J., Reichenbach D. et al. Characterisation of the early lesion of “degenerative” valvular aortic stenosis: histological and immunohistochemical studies. Circulation 1994;90:844-53.; Nishimura R.A., Otto C.M., Bonow R.O. et al. 2014 AHA/ ACC Guideline for the Management of Patients With Valvular Heart Disease: executive summary: a report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines. Circulation 2014;129:2440-92.; Carabello B.A. Evaluation and management of patients with aortic stenosis. Circulation 2002;105: 1746-50.; Gould K.L., Carabello B.A. Why angina in aortic stenosis with normal coronary arteriograms? Circulation 2003;107:3121-3.; Olshansky B. Syncope: overview and approach to management. In Syncope: mechanisms and management. Armonk, N.Y.: Futura;1998.; Arthur W., Kaye G. The pathophysiology of common causes of syncope. Postgrad Med J 2000;76: 750-3.; McMurray J.J., Adamopoulos S., Anker S.D. et al. ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure. Eur Heart J 2012; 33(14):1787-847.; Lips D.J., DeWindt L.J., van Kraaij D.J. et al. Molecular determinants of myocardial hypertrophy and failure: alternative pathways for beneficial and maladaptive hypertrophy. Eur Heart J 2003;24: 883-96.; Palmieri V., Watchtell K., Gerdts E. et al. LV function and haemodynamic features of inappropriate LVH in patients with systemic hypertension. Am. Heart J 2001;141:784-91.; Ingwall J.S. Energy metabolism in heart failure and remodelling. Cardiovasc Res 2009;81:412-9.; Neubauer S. The failing heart - an engine out of fuel. N Engl J Med 2007;356:1140-51.; Ventura-Clapier R., Garnier A., Veksler V. Energy metabolism in heart failure, J Physiol 2004;555: 1-13.; Taegtmeyer H. Switching metabolic genes to build a better heart. Circulation 2002; 106:2043-5.; Rimbaud S., Sanchez H., Garnier A. et al. Stimulus specific changes of energy metabolism in hypertrophied heart. J Mol Cell Cardiol 2009;46:952-9.; Lei B., Lionetti V., Young M.E. et al. Paradoxical downregulation of the glucose oxidation pathway despite enhanced flux in severe heart failure. J Mol Cell Cardiol 2004;36:567-76.; Razeghi P., Young M.E., Alcorn J.L. et al. Metabolic gene expression in fetal and failing human heart. Circulation 2001;104:2923-31.; Leong H.S., Brownsey R.W., Kulpa J.E., Allard M.F. Glycolysis and pyruvate oxidation in cardiac hypertrophy - why so unbalanced? Comp Biochem Physiol Mol Integr Physiol 2003;135:499-513.; Taegtmeyer H. Genetics of energetics: transcriptional responses in cardiac metabolism, Ann Biomed Eng 2000;28:871-6.; Saks V., Dzeja P., Schlattner U., et al. Cardiac system bioenergetics: metabolic basis of Frank-Starling law. J Physiol 2006;571:253-73.; Marcil M., Ascah A., Matas J. et al. Compensated volume overload increases the vulnerability of heart mitochondria without affecting their functions in the absence of stress, J Mol Cell Cardiol 2006;41:998-1009.; Tsutsui H., Ide T., Kinugawa S. Mitochondrial oxidative stress, DNA damage, and heart failure. Antioxid. Redox. Signal 2006;8:1737-44.; Tsutsui H., Kinugawa S., Matsushima S. Mitochondrial oxidative stress and dysfunction in myocardial remodelling. Cardiovasc Res 2009;81:449-56.; Twig G., Elorza A., Molina A.J. et al. Fission and selective fusion govern mitochondrial segregation and elimination by autophagy. EMBO J 2008;27:433-46.; Dzeja P.P., Terzic A. Phosphotransfer networks and cellular energetics. J Exp Biol 2003;206:2039-47.; Gupta A., Gupta S., Young D. et al. Impairment of ultrastructure and cytoskeleton during progression of cardiac hypertrophy to heart failure. Lab Invest 2010;90:520-30.; Mudd J.O., Kass D.A. Tackling heart failure in the twenty-first century. Nature 2008;451:919-28.; Kosarev VV, Babanov SA Pharmacotherapy of coronary heart disease: the focus cytoprotectors. Russkiy Meditsinskiy Zhurnal 2011; 19 (2): 1-4. In Russian (Косарев В.В., Бабанов С.А. Фармакотерапия ишемической болезни сердца: в фокусе цитопротекторы. Русский Медицинский Журнал 2011;19(2):1-4).; Zaitsev VI, Davydova IV Potashev SW. The experience of clinical application of trimetazidine in patients with essential hypertension and heart rhythm disturbances. Ukrainian Cardiology Journal 2008; 1: 105-9. In Russian (Зайцева В.И., Давыдова И.В., Поташев С.В. Опыт клинического применения триметазидина у больных с эссенциальной гипертензией и нарушениями сердечного ритма. Український кардіологічний журнал 2008.; 1: 105-9).; Kosarev VV, Babanov SA Clinical pharmacology of drugs used in cardiovascular diseases. Samara: Ofort; 2010. In Russian (Косарев В.В., Бабанов С.А. Клиническая фармакология лекарственных средств, применяемых при сердечно-сосудистых заболеваниях. Самара: Офорт; 2010).; Kosarev VV, Babanov SA Pharmacotherapy of coronary heart disease: the focus - cytoprotectors. Kardionevrologiya 2012; 1 (157): 60-5. In Russian (Косарев В.В., Бабанов С.А. Фармакотерапия ишемической болезни сердца: в фокусе – цитопротекторы. Кардионеврология 2012; 1(157): 60-5).; Kuznetsov VI, Chorbinskaya SA, Vyalov SS, et al. Angiozil® retard in the treatment and prevention of arrhythmias. Effektivnaya Farmakoterapiya v Kardiologii i Angiologii 2008; 2: 6-11. In Russian (Кузнецов В.И., Чорбинская С.А., Вялов С.С., и др. Ангиозил® ретард в лечении и профилактике аритмий. Эффективная Фармакотерапия в Кардиологии и Ангиологии 2008; 2: 6-11).; Xu X, Zhang W, Zhou Y et al. Effect of TMZ on Recurrent Angina Pectoris and Left Ventricular Structure in Elderly Multivessel Coronary Heart Disease Patients with Diabetes Mellitus After Drug-Eluting Stent Implantation: A Single-Centre, Prospective, Randomized, Double-Blind Study at 2-Year Follow-Up. Clinical Drug Investigation 2014; 34(4):251-8.; AkgüllüÇ., Saruhan T., Eryilmaz U., et al. The first histopathological evidence of trimetazidine for the prevention of contrast-induced nephropathy. Ren Fail 2014;36(4):575-80.; Chen J., Zhou S., Jin J., et al. Chronic treatment with trimetazidine after discharge reduces the incidence of restenosis in patients who received coronary stent implantation: a 1-year prospective followup study. Int J Cardiol 2014;174(3):634-9.; Tallarico D., Rizzo V., di Maio F., et al. Myocardial Cytoprotection by Trimetazidine Against Anthracycline-Induced Cardiotoxicity in Anticancer Chemotherapy. Angiology 2003; 54: 219-27.; Martsevich SY, Kutishenko NP, Ginzburg ML, et al. The KARDIOKANON Study: a way to address the issue of clinical equivalence of original and generic drugs. Ration Pharmacother Cardiol 2012; 8 (2) 179-84. In Russian (Марцевич С.Ю., КутишенкоН.П., Гинзбург М.Л., и др. Исследование КАРДИОКАНОН: способ решения вопроса о клинической эквивалентности оригинальных и воспроизведенных препаратов. Рациональная Фармакотерапия в Кардиологии 2012; 8(2); 179-84).; Shostak NA, Smolenskaya OG, Panov AV, et al. Possibilities of therapeutic cardiac cytoprotection in the treatment of complex coronary artery disease. Rossiyskiy Kardiologicheskiy Zhurnal 2009; 6: 25-8. In Russian. (Шостак Н.А., Смоленская О.Г., Панов А.В., и др. Возможности терапевтической кардиоцитопротекции в комплексно терапии ИБС. Российский Кардиологический Журнал 2009;6:25-8).; Afanasiev V.V. Trimetazidine. New to old (or what should be done to the drug worked, as you want). Symposium: The ambiguity of cardiovascular manifestations in patients receiving therapeutic conditions. XIII Congress of Physicians of the Northwestern Federal District. 12-13 March 2014; Saint-Petersburg. Available at: http://www.congress.spb.ru/spbto782014/agenda/Trimetazidin_Novoe_o_starom_ili_chto_nuzhno_sdelat_chtoby_preparat_rabotal_tak_kak_vam_khochetsya/. Retrieved 08/20/2015. In Russian. (Афанасьев В.В. Триметазидин. Новое о старом (или что нужно сделать, чтобы препарат работал, так как вам хочется). Симпозиум: Многозначность сосудистых проявлений у больных в условиях терапевтического приёма. XIII конгресс терапевтов СЗФО. 12-13 марта 2014; Санкт-Петербург. Доступно на: http://www.congress.spb.ru/spbto782014/agenda/Trimetazidin_Novoe_o_starom_ili_chto_nuzhno_sdelat_chtoby_preparat_rabotal_tak_kak_vam_khochetsya/. Проверено 20.08.2015).; Towler D. A. Molecular and Cellular Aspects of Calcific Aortic Valve Disease. Circ Res 2013; 113(2): 198-208.; Rashedi N., Otto C.M. Aortic Stenosis: Changing Disease Concepts. J Cardiovasc Ultrasound 2015;23(2):59-69.; https://www.rpcardio.com/jour/article/view/174

الاتاحة: https://www.rpcardio.com/jour/article/view/174
https://doi.org/10.20996/1819-6446-2015-11-4-431-437